Evaluation of cardiac function by echocardiography in patients with interstitial lung disease, divided by ILD group

V. Martínez Vázquez (Ciudad de Mexico, Mexico), A. Orea Tejeda (Ciudad de Mexico, Mexico), D. González Islas (Ciudad de Mexico, Mexico), M. Quintero Martínez (Ciudad de Mexico, Mexico), R. Sánchez Santillan (Ciudad de Mexico, Mexico), Y. Gastelum Ayala (Ciudad de Mexico, Mexico), O. Martínez Reyna (Ciudad de Mexico, Mexico), I. Pérez García (Ciudad de Mexico, Mexico), N. Martínez Luna (Ciudad de Mexico, Mexico), M. Gómez Martínez (Ciudad de Mexico, Mexico), L. Verdeja Vendrell (Ciudad de Mexico, Mexico), I. Buendía Roldan (Ciudad de Mexico, Mexico), M. Mejía Ávila (Ciudad de Mexico, Mexico), R. Robles Hernández (Ciudad de Mexico, Mexico), A. Velázquez Montes (Ciudad de Mexico, Mexico)

Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Martínez Vázquez (Ciudad de Mexico, Mexico), A. Orea Tejeda (Ciudad de Mexico, Mexico), D. González Islas (Ciudad de Mexico, Mexico), M. Quintero Martínez (Ciudad de Mexico, Mexico), R. Sánchez Santillan (Ciudad de Mexico, Mexico), Y. Gastelum Ayala (Ciudad de Mexico, Mexico), O. Martínez Reyna (Ciudad de Mexico, Mexico), I. Pérez García (Ciudad de Mexico, Mexico), N. Martínez Luna (Ciudad de Mexico, Mexico), M. Gómez Martínez (Ciudad de Mexico, Mexico), L. Verdeja Vendrell (Ciudad de Mexico, Mexico), I. Buendía Roldan (Ciudad de Mexico, Mexico), M. Mejía Ávila (Ciudad de Mexico, Mexico), R. Robles Hernández (Ciudad de Mexico, Mexico), A. Velázquez Montes (Ciudad de Mexico, Mexico). Evaluation of cardiac function by echocardiography in patients with interstitial lung disease, divided by ILD group. 3536

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD)
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009


HRCT imaging of lung parenchyma in chronic heart failure (CHF) patients: correlation with pulmonary function tests
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008

The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016

Patients profile and pulmonary rehabilitation in interstitial lung disease
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Functional status following pulmonary rehabilitation in patients with interstitial lung disease
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021


Right ventricular dimensions on CTPA predict pulmonary hypertension and prognosis in interstitial lung disease (ILD)
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Diagnostic accuracy of echocardiography in pulmonary hypertension due to interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018

The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment
Source: International Congress 2016 – IPF treatment I
Year: 2016


Efficacy of pulmonary rehabilitation in patients with interstitial lung disease
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012


Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant
Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Year: 2010


The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014

Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016

Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008



A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease
Source: ERJ Open Res, 4 (2) 00124-2017; 10.1183/23120541.00124-2017
Year: 2018



Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011



Diaphragm ultrasound in patients with interstitial lung disease (ILD): a prospective study.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016